NCT06768138View on ClinicalTrials.gov

Intra-Arterial Thrombolysis After SUCCESSful Reperfusion in Anterior Circulation Ischemic Stroke

PHASE3RecruitingINTERVENTIONAL
Enrollment

626

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

September 16, 2028

Study Completion Date

July 1, 2029

Conditions
Stroke, Acute Ischemic
Interventions
DRUG

Intra-arterial infusion of Alteplase

Patients enrolled in the experimental arm will receive intra-arterial thrombolysis with Alteplase. The dose of Intra-arterial Alteplase is 0.225 mg/kg body weight with a maximal dose of 20 mg

Trial Locations (1)

54000

RECRUITING

CHRU Nancy, Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER